Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Dermatology and Therapy
|
June 19, 2024
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis
April W Armstrong, Andrew F Alexis, Andrew Blauvelt, et al.
Neurorehabilitation
|
June 10, 2019
Cognitive impairment and health-related quality of life following traumatic brain injury
Nikos Gorgoraptis, Joanna Zaw-Linn, Claire Feeney, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis
Jashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
The Journal of Dermatological Treatment
|
April 10, 2023
Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial
Carsten Flohr, Michael J Cork, Michael R Ardern-Jones, et al.
International Archives of Allergy and Immunology
|
February 23, 2026
Efficacy of Abrocitinib and Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals Recommended by Experts in China
Zuotao Zhao, Xing-Hua Gao, Yangfeng Ding, et al.
Clinical Endocrinology
|
May 20, 2025
Radiological Activity Score (RAS)-MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi-Ethnic Thyroid Eye Disease Population
Malik Moledina, Vickie Lee, Kunwar Bhatia, et al.
Advances in Therapy
|
July 13, 2022
Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis
Jashin J Wu, Marie-Hélène Lafeuille, Bruno Emond, et al.
JAMA Dermatology
|
June 4, 2020
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
Jonathan I Silverberg, Eric L Simpson, Jacob P Thyssen, et al.
American Journal of Clinical Dermatology
|
May 6, 2021
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
Jonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
Dermatology and Therapy
|
July 2, 2024
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda J Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Dermatology and Therapy
|
June 19, 2024
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis
April W Armstrong, Andrew F Alexis, Andrew Blauvelt, et al.
Neurorehabilitation
|
June 10, 2019
Cognitive impairment and health-related quality of life following traumatic brain injury
Nikos Gorgoraptis, Joanna Zaw-Linn, Claire Feeney, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis
Jashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
The Journal of Dermatological Treatment
|
April 10, 2023
Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial
Carsten Flohr, Michael J Cork, Michael R Ardern-Jones, et al.
International Archives of Allergy and Immunology
|
February 23, 2026
Efficacy of Abrocitinib and Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals Recommended by Experts in China
Zuotao Zhao, Xing-Hua Gao, Yangfeng Ding, et al.
Clinical Endocrinology
|
May 20, 2025
Radiological Activity Score (RAS)-MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi-Ethnic Thyroid Eye Disease Population
Malik Moledina, Vickie Lee, Kunwar Bhatia, et al.
Advances in Therapy
|
July 13, 2022
Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis
Jashin J Wu, Marie-Hélène Lafeuille, Bruno Emond, et al.
JAMA Dermatology
|
June 4, 2020
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
Jonathan I Silverberg, Eric L Simpson, Jacob P Thyssen, et al.
American Journal of Clinical Dermatology
|
May 6, 2021
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
Jonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
Dermatology and Therapy
|
July 2, 2024
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda J Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Page
of 4